Clinical trial · Observational
Prospective Observational Study Comparing the Use of Circular (Orvil) and Linear Stapler for Intracorporeal Esophagojejunostomy
NCT05007912CI-TRIAL-00053338unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prospective observational study comparing the use of circular (Orvil) and linear stapler for intracorporeal esophagojejunostomy. Patients with adenocaricinoma involving the esophagogastric junction or the gastric cardia are observed. The two methods of esophagojejunostomy are compared.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Stomach Neoplasm | Gastric Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Esophagojejunostomy type | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Orvil Group
- description
- Group that used the Orvil (circular stapler) for esophagojejunostomy
- interventionNames
- Procedure: Esophagojejunostomy type
- label
- Linear Group
- description
- Group that used the linear stapler for esophagojejunostomy
- interventionNames
- Procedure: Esophagojejunostomy type
Primary outcomes (1)
- measure
- Anastomosis complication
- timeFrame
- within 1 year
- description
- including anastomosis leakage, stenosis, bleeding of the esophagojejunostomy
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosed as gastric adenocarcinoma * Involving the esophagogastric junction or gastric cardia * Age 18 - 80 years * Anticipated to undergo laparoscopic total or proximal gastrectomy * cT1-T4a Exclusion Criteria: * Previous history of gastrectomy * Neoadjuvant chemotherapy or radiotherapy for gastric cancer * Invasion to other organs * Open conversion
References
Publications (0)
Data not yet available
No reference posted for this study.